Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis
Sofya Tishina, Alina Dahlhaus, Marta Manik, Lejla Mulalic, Janine Murr, Michael Kotliar, Hassan Rakhsh-Khorshid, Myrto Kostopoulou, Florian Hocher, Jenny Stroh, Julia Beck, Riley M Williams, Gülce G Balta, Fanyu Liu, Ali T Abdallah, Christina M Bebber, Moritz Reese, Jonathan K M Lim, Alexander Quaas, Johannes Brägelmann, Manolis Pasparakis, Filippo Beleggia, Siddharth Balachandran, Anna Trauzold, Gianmaria Liccardi, Igor Astsaturov, Maximilian Reichert, Ariadne Androulidaki, Silvia von Karstedt · 2026
Read Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis by Sofya Tishina, Alina Dahlhaus, Marta Manik, Lejla Mulalic, Janine Murr, Michael Kotliar, Hassan Rakhsh-Khorshid, Myrto Kostopoulou, Florian Hocher, Jenny Stroh, Julia Beck, Riley M Williams, Gülce G Balta, Fanyu Liu, Ali T Abdallah, Christina M Bebber, Moritz Reese, Jonathan K M Lim, Alexander Quaas, Johannes Brägelmann, Manolis Pasparakis, Filippo Beleggia, Siddharth Balachandran, Anna Trauzold, Gianmaria Liccardi, Igor Astsaturov, Maximilian Reichert, Ariadne Androulidaki, Silvia von Karstedt (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13269921.txt.
Description
Sofya Tishina and co-authors published a journal article in 2026 on a weakness in pancreatic cancer, one of the deadliest cancers. Its main driver gene, KRAS, switches on an interferon program, a cell alarm system, that loads cancer cells with proteins for a form of cell death called necroptosis. Removing one guard protein then triggers that death.
In mouse models, deleting the guard protein wiped out most early pancreatic lesions. Drug blockade of the same guard cut tumor burden in aggressive mouse models and in mini-tumors grown from patient tissue. A cross-cancer analysis linked the death program to Ras pathway activity and interferon signatures. The authors present the alarm program as a treatment opening in this cancer.
Catalog record
| CREATOR | Sofya Tishina, Alina Dahlhaus, Marta Manik, Lejla Mulalic, Janine Murr, Michael Kotliar, Hassan Rakhsh-Khorshid, Myrto Kostopoulou, Florian Hocher, Jenny Stroh, Julia Beck, Riley M Williams, Gülce G Balta, Fanyu Liu, Ali T Abdallah, Christina M Bebber, Moritz Reese, Jonathan K M Lim, Alexander Quaas, Johannes Brägelmann, Manolis Pasparakis, Filippo Beleggia, Siddharth Balachandran, Anna Trauzold, Gianmaria Liccardi, Igor Astsaturov, Maximilian Reichert, Ariadne Androulidaki, Silvia von Karstedt |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 104506 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |